共 50 条
Discontinued drugs in 2008: oncology drugs
被引:18
|作者:
Williams, Robert
[1
]
机构:
[1] Canc Res UK, Drug Dev Off, London WC2A 3PX, England
关键词:
1D09C3;
4-demethylpenclomedine;
ARQ-171;
AZD-4992;
CNF-1010;
DN-101;
FCE-28068;
FCE-28069;
folitixorin calcium;
huMy9-6-DM4;
INNO-305;
mitumprotimut-T;
MLN-8054;
N-acetylcysteine;
PD-0325901;
phosphomannopentaose sulfate;
PI-166;
SGX-523;
spisulosine;
Symadex;
tozasertib lactate;
varalanib;
zanolimumab;
ATTRITION RATES;
D O I:
10.1517/13543780903151806
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The failure of drug candidates in clinical development remains a critical issue for the pharmaceutical and biotechnology industries. This article documents those oncology drugs discontinued in 2008 and briefly reviews reasons for termination of development. Source information was derived from a search of the Pharmaprojects database for drugs reaching phase I - III clinical trials.
引用
收藏
页码:1581 / 1594
页数:14
相关论文